Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Divalproex sodium, an anticonvulsant and antikindling agent and gamma-aminobutyric acid enhancer, has been proposed as an alternative to benzodiazepines for treating alcohol withdrawal. This study reports on a randomized, double-blind, placebo-controlled trial of divalproex sodium in acute alcohol withdrawal. METHODS: Thirty-six hospitalized patients experiencing moderate alcohol withdrawal as measured by a score of at least 10 on the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar) were randomized to receive either divalproex sodium 500 mg three times per day for 7 days or matched placebo in a double-blind manner. All subjects received a baseline dose of oxazepam and had additional oxazepam available as a rescue medication in accordance with a standard, symptom-triggered detoxification protocol. Mean total milligrams of oxazepam received, progression of withdrawal symptoms, psychological distress as measured by the Symptom Checklist-90, side effects, and adverse outcomes were compared between groups. RESULTS: Use of divalproex sodium resulted in less use of oxazepam (p < 0.033). Group differences seemed primarily driven by those subjects who experienced symptoms above threshold level (CIWA-Ar >or=10) after 12 hr. The progression in severity of withdrawal symptoms (increase in CIWA-Ar above baseline) was also significantly greater in the placebo group (p < 0.05). CONCLUSIONS: This placebo-controlled pilot study suggests that divalproex sodium significantly affects the course of acute alcohol withdrawal and reduces the need for treatment with a benzodiazepine. A more aggressive loading dose strategy may demonstrate a more robust or earlier response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Kindling as a Model for Alcohol Withdrawal Syndromes
Ballenger, J. C., & Post, R. M. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.1.1 · Cited by 463
Mayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434
Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid
Hillbom, M., Tokola, R., Kuusela, V., Kärkkäinen, P., Källi-Lemma, L., Pilke, A., & Kaste, M. (1989) · Alcohol · doi:10.1016/0741-8329(89)90022-0 · Cited by 81
Sodium valproate in the treatment of the alcohol withdrawal syndrome
Lambie, D. G., Johnson, R. H., Vijayasenan, M. E., & Whiteside, E. A. (1980) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048678009159381 · Cited by 59
Cited by
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Delirium Tremens: Assessment and Management
Grover, S., & Ghosh, A. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.012 · Cited by 416
Krystal, J. H., Petrakis, I. L., Mason, G., Trevisan, L., & D'Souza, D. C. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00054-8 · Cited by 314
The alcohol withdrawal syndrome
McKeon, A., Frye, M. A., & Delanty, N. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.128322 · Cited by 269
Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond
Sachdeva, A. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/13407.6538 · Cited by 141
“, concluded that Valproic acid significantly affects the course of alcohol withdrawal and reduces the need for treatment with a benzodiazepine [61,62].”
Background
Metadata
- Authors
- Reoux, J. P., Saxon, A. J., Malte, C. A., Baer, J. S., & Sloan, K. L.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2001-09
- Volume
- 25
- Issue
- 9
- Pages
- 1324-1329
- ISSN
- 0145-6008 (ISSN-L)
- OpenAlex
- W2095103357
- Cited by
- 112
- References
- 5
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial. https://app.cochat.ai/papers/10.1097/00000374-200109000-00012
- The paper
- Reoux, J. P., Saxon, A. J., Malte, C. A., Baer, J. S., & Sloan, K. L. (2001). Divalproex Sodium in Alcohol Withdrawal: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1097/00000374-200109000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.